Acute Hepatic Porphyria (AHP) Treatment Market : Demand, Insights and Forecast up to 2030

Global Acute Hepatic Porphyria (AHP) Treatment Market: Overview

Porphyrias are a set of metabolic disorders, each representing a defect in one of the eight enzymes in the heme biosynthetic pathway resulting in the accumulation of organic compounds called porphyrins. This leads to the clinical and biochemical profile typical for each porphyria. Hepatic porphyrias cause enzyme deficiency occurs in the liver.

Read Report Overview –

Acute hepatic porphyria (AHP) is one of the types of hepatic porphyria. Porphyrias can be classified into acute or cutaneous. Cutaneous porphyrias are rare inherited metabolic disorders that cause blistering of the skin, pain, and/or redness and swelling in sun-exposed areas.

In people with genetic defect, one of the enzymes in the pathway that creates heme is deficient and causes increase in aminolevulinic acid synthase 1 in the blood and build up porphobilinogen throughout the body

Left untreated, acute porphyria attacks can result in respiratory failure, peripheral neuropathy, quadriplegia, life-threatening paralysis, irreversible neuronal damage, and death

Request a PDF Sample –

Key Driver of Global Acute Hepatic Porphyria (AHP) Treatment Market

  • According to NCBI, the global prevalence of acute hepatic porphyria is projected to range from one in 500 to one in 50,000 individuals. In most regions, acute intermittent porphyria (AIP) is the most common, and ALA dehydratase-deficiency porphyria (ALAD) is the least common.
  • The prevalence of clinical AIP is reported to be 5 to 10 per 100,000 individuals, and the prevalence of genetic mutations of AIP is approximately one in 1675 individuals. This high rate of prevalence is likely to drive the demand for treatment of acute hepatic porphyria.

Request for Analysis of COVID19 Impact on Acute Hepatic Porphyria (AHP) Treatment Market –

North America to Account for Major Share of Global Acute Hepatic Porphyria (AHP) Treatment Market

  • In terms of region, the global acute hepatic porphyria (AHP) treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period.
  • North America is anticipated to account for significant share of the global market due to well-defined reimbursement policies from public and private health insurance firms that help provide patients easy access of diagnosis and extensive research & development activities. In the U.S., approximately 5,000 people experience one or more of acute hepatic porphyria attacks annually.
  • Asia Pacific is expected to account for substantial share of the market in terms of revenue during the forecast period due to increase in patient population

Pre Book Acute Hepatic Porphyria (AHP) Treatment Market Research –<ype=S

Key Players Operating in Global Acute Hepatic Porphyria (AHP) Treatment Market

Major players operating in the global acute hepatic porphyria (AHP) treatment market are:

  • Alnylam Pharmaceuticals, Inc.
  • Lundbeck A/S
  • Alleviare Life Sciences Pvt. Ltd.
  • Other Prominent Players

More Trending Reports by Transparency Market Research –

Tamiflu Oseltamivir Phosphate Market:

Read our Case study at

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453



What do you think?

Written by Pooja


Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.



Hib Vaccine Market Set to Record Exponential Growth by 2030

Cisco 700-150 Exam Dumps, 100% Free 700-150 Questions